Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Exclusion Criteria

• •1. AST or ALT 2 \> x upper limit of normal.
• •2. Abnormal bilirubin (total bilirubin \> 1.2 mg/dL, direct bilirubin \> 0.4 mg/dL)
• •3. Creatinine \> 2.0 mg/dl.
• •4. Known coronary artery disease or EKG suggestive of coronary artery disease unless cardiac clearance for apheresis is obtained from a cardiologist.
• •5. Known active infection such as Hepatitis B, Hepatitis C, or Human Immunodeficiency Virus (HIV)
• •6. Pregnancy assessed by a positive serum pregnancy test or breastfeeding mothers
• •7. Use of immunosuppressive medication within one month of enrollment including but not limited to cyclosporine, tacrolimus, sirolimus, and chemotherapy.
• •8. Anticoagulation other than ASA.
• •9. Hemoglobin \< 10 g/dl or platelets \< 100 k/ml
• •10. Is unable or unwilling to provide informed consent
• •11. Presence of any other physical or psychological medical condition that, in the opinion of the investigator, would preclude participation